{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:34Z","timestamp":1777870414486,"version":"3.51.4"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40620-018-0470-x","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T10:32:07Z","timestamp":1516185127000},"page":"635-643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Nutritional therapy in autosomal dominant polycystic kidney disease"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2779-4181","authenticated-orcid":false,"given":"Biagio R.","family":"Di Iorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamasco","family":"Cupisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Di Lullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"Suppl 69","key":"470_CR1","first-page":"119","volume":"34","author":"F Liut","year":"2017","unstructured":"Liut F, Izzi C, Dallera N, Scolari F (2017) ADPKD e cuore. G Ital Nefrol 34(Suppl 69):119\u2013130","journal-title":"G Ital Nefrol"},{"key":"470_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/ki.1984.154","volume":"26","author":"DN Churchill","year":"1984","unstructured":"Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH (1984) Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 26:190\u2013193","journal-title":"Kidney Int"},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","volume":"63","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, Grantham JJ (2003) Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant poly- cystic kidneys. Kidney Int 63:1983\u20131994","journal-title":"Kidney Int"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP (2004) Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279:40419\u201340430","journal-title":"J Biol Chem"},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone VH 2nd, Wang X, Harris PC, Torres VE (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323\u20131326","journal-title":"Nat Med"},{"key":"470_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","volume":"30","author":"T Yamaguchi","year":"1997","unstructured":"Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ (1997) Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30:703\u2013709","journal-title":"Am J Kidney Dis"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1681\/ASN.2006030251","volume":"17","author":"S Nagao","year":"2006","unstructured":"Nagao S (2006) Increased Water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol 17:2220\u20132227","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"470_CR8","doi-asserted-by":"publisher","first-page":"F261","DOI":"10.1152\/ajprenal.00345.2014","volume":"308","author":"K Hopp","year":"2015","unstructured":"Hopp K, Wang X, Ye H, Irazabal MV, Harris PC, Torres VE (2015) Effects of hydration in rats and mice with polycystic kidney disease. Am J Physiol Renal Physiol 308(3):F261\u2013F266","journal-title":"Am J Physiol Renal Physiol"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2215\/CJN.04180609","volume":"5","author":"I Barash","year":"2010","unstructured":"Barash I, Ponda MP, Goldfarb DS, Skolnik EY (2010) A pilot clinical study to evaluate changes in urine osmolality and urine camp in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 5:693\u2013697","journal-title":"Clin J Am Soc Nephrol"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfu093","volume":"29","author":"E Higashihara","year":"2014","unstructured":"Higashihara E, Kikuo Nutahara K, Tanbo M, Hara H, Miyazaki I, Kobayashi H, Nitatori T (2014) Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease? Nephrol Dial Transplant 29:1710\u20131719","journal-title":"Nephrol Dial Transplant"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.ajkd.2016.07.023","volume":"68","author":"OW Amro","year":"2016","unstructured":"Amro OW, Paulus JK, Noubary F, Perrone RD (2016) Low-osmolar diet and adjusted water intake for vasopressin reduction in autosomal dominant polycystic kidney disease: a pilot randomized controlled trial. AM J Kidney Dis 68:882\u2013891","journal-title":"AM J Kidney Dis"},{"key":"470_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/ckj\/sfw153","volume":"10","author":"R El-Damanawi","year":"2017","unstructured":"El-Damanawi R, Harris T, Sandford RN, Karet Frankl FE, Hiemstra TF (2017) Patient survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey. Clin Kidney J 10:305\u2013309","journal-title":"Clin Kidney J"},{"issue":"2","key":"470_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.clnu.2016.01.003","volume":"36","author":"JM Taylor","year":"2017","unstructured":"Taylor JM, Hamilton-Reeves JM, Sullivan DK, Gibson CA, Creed C, Carlson SE, Wesson DE, Grantham JJ (2017) Diet and polycystic kidney disease: a pilot intervention study. Clin Nutr 36(2):458\u2013466","journal-title":"Clin Nutr"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ki.2013.23","volume":"84","author":"CJ Wang","year":"2013","unstructured":"Wang CJ, Grantham JJ, Wetmore JB (2013) The medicinal use of water in renal disease. Kidney Int 84:45\u201353","journal-title":"Kidney Int"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000445959","volume":"43","author":"WF Clark","year":"2016","unstructured":"Clark WF, Sontrop JM, Huang SH, Moist L, Bouby N, Bankir L (2016) Hydration and chronic kidney disease progression: a critical review of the evidence. Am J Nephrol 43:281\u2013292","journal-title":"Am J Nephrol"},{"issue":"25","key":"470_CR16","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367(25):2407\u20132418","journal-title":"N Engl J Med"},{"issue":"3","key":"470_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ndt\/gfv456","volume":"31","author":"RT Gansevoort","year":"2016","unstructured":"Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, Devuyst O, Drechsler C, Eckardt KU, Emma F, Knebelmann B, Le Meur Y, Massy ZA, Ong AC, Ortiz A, Schaefer F, Torra R, Vanholder R, Wi\u0119cek A, Zoccali C, Van Biesen W (2016). Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol Dial Transplant 31(3):337\u2013348","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"470_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2215\/CJN.04310709","volume":"5","author":"AB Chapman","year":"2010","unstructured":"Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW (2010) HALT T polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol 5(1):102\u2013109","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"470_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","volume":"91","author":"VE Torres","year":"2017","unstructured":"Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91(2):493\u2013500","journal-title":"Kidney Int"},{"issue":"8","key":"470_CR20","doi-asserted-by":"publisher","first-page":"e0161043","DOI":"10.1371\/journal.pone.0161043","volume":"11","author":"JM Taylor","year":"2016","unstructured":"Taylor JM, Ptomey L, Hamilton-Reeves JM, Sullivan DK, Creed C, Carlson SE, Wesson DE, Grantham JJ, Gibson CA (2016) Experiences and perspectives of polycystic kidney disease patients following a diet of reduced osmoles, protein, and acid precursors supplemented with water: a qualitative study. PLoS One 11(8):e0161043","journal-title":"PLoS One"},{"issue":"6","key":"470_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.ajkd.2016.05.019","volume":"68","author":"CM Rebholz","year":"2016","unstructured":"Rebholz CM, Crews DC, Grams ME, Steffen LM, Levey AS, Miller ER 3rd, Appel LJ, Coresh J (2016) DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis 68(6):853\u2013861","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"470_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.kint.2016.11.032","volume":"92","author":"K Nomura","year":"2017","unstructured":"Nomura K, Asayama K, Jacobs L, Thijs L, Staessen JA (2017) Renal function in relation to sodium intake: a quantitative review of the literature. Kidney Int 92(1):67\u201378","journal-title":"Kidney Int"},{"issue":"17","key":"470_CR23","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112(17):2627\u20132633","journal-title":"Circulation"},{"issue":"2","key":"470_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3945\/ajcn.113.073148","volume":"99","author":"AR Chang","year":"2014","unstructured":"Chang AR, Lazo M, Appel LJ, Guti\u00e9rrez OM, Grams ME (2014) High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 99(2):320\u2013327","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"470_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3945\/an.113.004812","volume":"4","author":"OM Guti\u00e9rrez","year":"2013","unstructured":"Guti\u00e9rrez OM (2013) The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know. Adv Nutr. 4(6):723\u2013729","journal-title":"Adv Nutr"},{"issue":"5","key":"470_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ki.2013.258","volume":"84","author":"M Tonelli","year":"2013","unstructured":"Tonelli M (2013) Serum phosphorus in people with chronic kidney disease: you are what you eat. Kidney Int 84(5):871\u2013873","journal-title":"Kidney Int"},{"issue":"9","key":"470_CR27","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","volume":"26","author":"CM O\u2019Seaghdha","year":"2011","unstructured":"O\u2019Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS (2011) Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 26(9):2885\u20132890","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"470_CR28","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2017-01157","volume":"102","author":"S Rechter De","year":"2017","unstructured":"De Rechter S, Bacchetta J, Godefroid N, Dubourg L, Cochat P, Maquet J, Raes A, De Schepper J, Vermeersch P, Van Dyck M, Levtchenko E, D\u2019Haese P, Evenepoel P, Mekahli D (2017) Evidence for bone and mineral metabolism alterations in children with autosomal dominant polycystic kidney disease. J Clin Endocrinol Metab 102(11):4210\u20134217","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"470_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","volume":"62","author":"B Iorio Di","year":"2013","unstructured":"Di Iorio B, Molony D, Bell C, Cucciniello E, Bellizzi V, Russo D, Bellasi A; INDEPENDENT Study Investigators (2013) Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis 62(4):771\u2013778","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"470_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2215\/CJN.03820411","volume":"7","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Bellasi A, Russo D; INDEPENDENT Study Investigators (2012) Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol. 7(3):487\u2013493","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"470_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nefro.2017.06.004","volume":"38","author":"Almudena P\u00e9rez-Torres","year":"2018","unstructured":"P\u00e9rez-Torres A, Gonz\u00e1lez Garcia ME, San Jos\u00e9-Valiente B, Bajo Rubio MA, Celadilla Diez O, L\u00f3pez-Sobaler AM, Selgas R (2017) Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics. Nefrologia Jul 26. pii:S0211\u20136995(17)30141-8. https:\/\/doi.org\/10.1016\/j.nefro.2017.06.004 [Epub ahead of print]","journal-title":"Nefrolog\u00eda"},{"issue":"1","key":"470_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12882-017-0593-7","volume":"18","author":"A Cupisti","year":"2017","unstructured":"Cupisti A, D\u2019Alessandro C, Finato V, Del Corso C, Catania B, Caselli GM, Egidi MF (2017) Assessment of physical activity, capacity and nutritional status in elderly peritoneal dialysis patients. BMC Nephrol 18(1):180","journal-title":"BMC Nephrol"},{"issue":"4","key":"470_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ki.1992.358","volume":"42","author":"HM Aukema","year":"1992","unstructured":"Aukema HM, Ogborn MR, Tomobe K, Takahashi H, Hibino T, Holub BJ. (1992) Effects of dietary protein restriction and oil type on the early progression of murine polycystic kidney disease. Kidney Int. 42(4):837\u2013842","journal-title":"Kidney Int"},{"issue":"2","key":"470_CR34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1681\/ASN.V102300","volume":"10","author":"HM Aukema","year":"1999","unstructured":"Aukema HM, Housini I, Rawling JM (1999) Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol 10(2):300\u2013308","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"470_CR35","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.V561355","volume":"5","author":"K Tomobe","year":"1994","unstructured":"Tomobe K, Philbrick D, Aukema HM, Clark WF, Ogborn MR, Parbtani A, Takahashi H, Holub BJ (1994) Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease. J Am Soc Nephrol 5(6):1355\u20131360","journal-title":"J Am Soc Nephrol"},{"key":"470_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000424411","volume":"115","author":"G Barsotti","year":"1995","unstructured":"Barsotti G, Cupisti A, Moriconi L, Cozza V, Falbo E, Gattai V, Pozzolini L, Meola M (1995) Effects of reduced protein intake in rats with congenital polycystic kidney without renal failure. Contrib Nephrol 115:137\u2013140","journal-title":"Contrib Nephrol"},{"issue":"1","key":"470_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1523-1755.2000.00835.x","volume":"57","author":"MR Ogborn","year":"2000","unstructured":"Ogborn MR, Nitschmann E, Weiler HA, Bankovic-Calic N (2000) Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 57(1):159\u2013166","journal-title":"Kidney Int"},{"issue":"5","key":"470_CR38","doi-asserted-by":"publisher","first-page":"e0155790","DOI":"10.1371\/journal.pone.0155790","volume":"11","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi T, Devassy JG, Monirujjaman M, Gabbs M, Aukema HM (2016) Lack of Benefit of early intervention with dietary flax and fish oil and soy protein in orthologous rodent models of human hereditary polycystic kidney disease. PLoS One 11(5):e0155790","journal-title":"PLoS One"},{"issue":"5","key":"470_CR39","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2015020132","volume":"27","author":"G Warner","year":"2016","unstructured":"Warner G, Hein KZ, Nin V, Edwards M, Chini CC, Hopp K, Harris PC, Torres VE, Chini EN (2016) Food restriction ameliorates the development of polycystic kidney disease. J Am Soc Nephrol 27(5):1437\u20131447","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"470_CR40","doi-asserted-by":"publisher","first-page":"F726-F731","DOI":"10.1152\/ajprenal.00551.2015","volume":"310","author":"KR Kipp","year":"2016","unstructured":"Kipp KR, Rezaei M, Lin L, Dewey EC, Weimbs T (2016) A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease. Am J Physiol Renal Physiol 310(8):F726-F731","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"470_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3181\/0811-RM-315","volume":"234","author":"CY Peng","year":"2009","unstructured":"Peng CY, Sankaran D, Ogborn MR, Aukema HM (2009) Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease. Exp Biol Med (Maywood) 234(7):737\u2013743","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"470_CR42","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME (1995) Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 5(12)2037\u20132034","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"470_CR43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1681\/ASN.V661634","volume":"6","author":"G Choukroun","year":"1995","unstructured":"Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Gr\u00fcnfeld JP, Jungers P (1995) Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6(6):1634\u20131642","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"470_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.kint.2017.01.021","volume":"92","author":"J Yamamoto","year":"2017","unstructured":"Yamamoto J, Nishio S, Hattanda F, Nakazawa D, Kimura T, Sata M, Makita M, Ishikawa Y, Atsumi T (2017) Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease. Kidney Int 92(2):377\u2013387","journal-title":"Kidney Int"},{"key":"470_CR45","doi-asserted-by":"crossref","unstructured":"Di Iorio BR, Di Micco L, Marzocco S, De Simone E, De Blasio A, Sirico ML, Nardone L, On Behalf Of Ubi Study Group (2017) Very low-protein diet (VLPD) reduces metabolic acidosis in subjects with chronic kidney disease: the \u201cNutritional Light Signal\u201d of the Renal Acid Load. Nutrients 9(1)","DOI":"10.3390\/nu9010069"},{"issue":"3","key":"470_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2215\/CJN.02430312","volume":"8","author":"N Goraya","year":"2013","unstructured":"Goraya N, Simoni J, Jo CH, Wesson DE. (2013) A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 8(3):371\u2013381","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"470_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNH.0b013e32835dcbbe","volume":"22","author":"N Goraya","year":"2013","unstructured":"Goraya N, Wesson DE (2013) Does correction of metabolic acidosis slow chronic kidney disease progression? Curr Opin Nephrol Hypertens 22(2):193\u2013197","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"470_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MOP.0000000000000202","volume":"27","author":"JJ Bissler","year":"2015","unstructured":"Bissler JJ. (2015) Therapies for polycystic kidney disease. Curr Opin Pediatr. 27(2):227\u2013232","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"470_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5301\/jn.5000014","volume":"25","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Aucella F, Conte G, Cupisti A, Santoro D (2012) A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study. J Nephrol. 25(3):437\u2013440","journal-title":"J Nephrol"},{"key":"470_CR50","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ajcn\/59.6.1356","volume":"59","author":"T Remer","year":"1994","unstructured":"Remer T, Manz F (1994) Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr 59:1356\u20131361","journal-title":"Am J Clin Nutr"},{"key":"470_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ajcn\/68.3.576","volume":"68","author":"LA Frassetto","year":"1998","unstructured":"Frassetto LA, Todd KM, Morris RJC, Sebastian A (1998) Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr 68:576\u2013583","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"470_CR52","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V971242","volume":"9","author":"GA Tanner","year":"1998","unstructured":"Tanner GA (1998) Potassium citrate\/citric acid intake improves renal function in rats with polycystic kidney disease. J Am Soc Nephrol 9(7):1242\u20131248","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"470_CR53","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/ki.1994.227","volume":"45","author":"VE Torres","year":"1994","unstructured":"Torres VE, Keith DS, Offord KP, Kon SP, Wilson DM (1994) Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int 45(6):1745\u20131753","journal-title":"Kidney Int"},{"issue":"1","key":"470_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12882-016-0296-5","volume":"17","author":"C D\u2019Alessandro","year":"2016","unstructured":"D\u2019Alessandro C, Piccoli GB, Calella P, Brunori G, Pasticci F, Egidi MF, Capizzi I, Bellizzi V, Cupisti A (2016) \u201cDietaly\u201d: practical issues for the nutritional management of CKD patients in Italy. BMC Nephrol 17(1):102","journal-title":"BMC Nephrol"},{"issue":"4","key":"470_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40620-017-0395-9","volume":"30","author":"R Magistroni","year":"2017","unstructured":"Magistroni R, Boletta A (2017) Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans. J Nephrol 30(4):511\u2013519","journal-title":"J Nephrol"},{"issue":"1","key":"470_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40620-017-0396-8","volume":"31","author":"Laura Girardat-Rotar","year":"2017","unstructured":"Girardat-Rotar L, Puhan MA, Braun J, Serra AL. (2017).Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-017-0396-8","journal-title":"Journal of Nephrology"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0470-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:39Z","timestamp":1777564659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/31\/5\/635\/8371443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0470-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}